health
Dr Reddy’s secures India rights of Takeda’s dengue vax; prepares H1 2027 rollout
By Info60 India Desk•Summary of reporting by pharma.economictimes.indiatimes.com•Sep 18, 2026•0 views•
Dr Reddy's Laboratories has secured exclusive rights to distribute Takeda's dengue vaccine, Qdenga, in India, set to launch in early 2027. This significant development aims to tackle the dengue burden in the country with a vaccine offering up to seven years of protection.
Hyderabad: Dr Reddy;s Laboratories has obtained exclusive rights to promote and distribute Takeda’s dengue vaccine, Qdenga across India’s private market.
The vaccine is anticipated to become available in the first half of 2027, the company said in a ... [2248 chars]
Read Full ArticleShare this story
Up next
Related Stories
What happens when middle-aged adults take creatine for 12 weeks? New study finds muscle gains even without structured exercise
The Economic Times
Study Links Oral Menopausal Hormone Therapy to Thrombotic Risk
Drug Topics
Smartphone retinal imaging could expand global eye care screening
News-Medical
Why does endometriosis only cause major pain for some?
Futurity
Are You Always Up Past Midnight? Study Reveals How Sleeping Late May Affect Your Body’s Cancer Defences
News18